Press Releases

All Releases

• Summary ToggleDexcom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2018 and Provides Initial 2019 Outlook

  Jan 7, 2019

  SAN DIEGO --(BUSINESS WIRE)--Jan. 7, 2019-- DexCom, Inc. (Nasdaq: DXCM), the leader in continuous glucose monitoring (“CGM”), today reported that it expects preliminary, unaudited revenue for the fourth quarter ended December 31, 2018 to exceed $331 million , an increase of at least 50% over the

  Read more
• Summary ToggleDexcom Announces Upcoming Conference Presentation

  Dec 18, 2018

  SAN DIEGO --(BUSINESS WIRE)--Dec. 18, 2018-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Kevin Sayer , Chairman, Chief Executive Officer and President, will present an update on the company at the J.P.

  Read more
• Summary ToggleDexCom Prices Offering of $750.0 Million of 0.75% Convertible Senior Notes

  Nov 28, 2018

  SAN DIEGO --(BUSINESS WIRE)--Nov. 28, 2018-- DexCom, Inc. (Nasdaq: DXCM) (“DexCom”) announced today the pricing of its offering of $750.0 million aggregate principal amount of 0.75% Convertible Senior Notes due 2023 (the “notes”) in a private placement to qualified institutional buyers pursuant to

  Read more
• Summary ToggleDexCom Announces Proposed Offering of $750 Million of Convertible Senior Notes

  Nov 26, 2018

  SAN DIEGO --(BUSINESS WIRE)--Nov. 26, 2018-- DexCom, Inc. (Nasdaq: DXCM) (“DexCom”) announced today that it intends to offer, subject to market conditions and other factors, $750 million aggregate principal amount of Convertible Senior Notes due 2023 (the “notes”) in a private placement to

  Read more
• Summary ToggleDexCom Announces Upcoming Conference Presentation

  Nov 21, 2018

  SAN DIEGO --(BUSINESS WIRE)--Nov. 21, 2018-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Steven Pacelli , Executive Vice President, Strategy and Corporate Development and Matthew Dolan , Vice President,

  Read more
• Summary ToggleDexcom and Verily Amend Collaboration and License Agreement

  Nov 20, 2018

  Amendment intended to reinforce joint product development targets, accelerate Dexcom’s efforts in Type 2 diabetes and improve its long-term profitability SAN DIEGO --(BUSINESS WIRE)--Nov. 20, 2018-- DexCom , Inc. ( NASDAQ:DXCM ), a leader in continuous glucose monitoring (CGM), and Verily, an

  Read more
• Summary ToggleDexcom to Host Investor Day on December 4, 2018

  Nov 7, 2018

  SAN DIEGO --(BUSINESS WIRE)--Nov. 7, 2018-- DexCom, Inc. (NASDAQ:DXCM) today announced that it will host an Investor Day on December 4, 2018 at the Laguna Cliffs Marriott in Dana Point, California . The event will include updates on the company’s innovation pipeline, business strategy, and

  Read more
• Summary ToggleDexCom Reports Third Quarter 2018 Financial Results

  Nov 6, 2018

  SAN DIEGO --(BUSINESS WIRE)--Nov. 6, 2018-- DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended September 30, 2018 . Third Quarter 2018 Highlights: Revenue grew 44% on a reported basis to $266.7 million versus the same quarter of the prior year

  Read more
• Summary ToggleDexcom G6® Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries with Diabetes in Early 2019

  Oct 18, 2018

  CMS approves coverage for Dexcom G6 CGM, the only CGM system recognized by Medicare that offers mobile device compatibility and no fingerstick calibration SAN DIEGO --(BUSINESS WIRE)--Oct. 18, 2018-- DexCom , Inc. ( NASDAQ:DXCM ), a leader in continuous glucose monitoring (CGM), announced today the

  Read more
• Summary ToggleDexCom Schedules Third Quarter 2018 Earnings Release and Conference Call for November 6, 2018 at 4:30 p.m. Eastern Time.

  Oct 8, 2018

  SAN DIEGO --(BUSINESS WIRE)--Oct. 8, 2018-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2018 financial results after market close on Tuesday, November 6, 2018 . Management will hold a conference call to review the company's third quarter 2018 performance

  Read more